ANTHONY MARESSO to Bacteriophages
This is a "connection" page, showing publications ANTHONY MARESSO has written about Bacteriophages.
Connection Strength
8.168
-
Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection. Int J Antimicrob Agents. 2025 Dec; 66(6):107613.
Score: 0.871
-
Phage-induced protection against lethal bacterial reinfection. Proc Natl Acad Sci U S A. 2025 Jun 03; 122(22):e2423286122.
Score: 0.855
-
Construction and characterization of DNA libraries from cultured phages and environmental viromes. Appl Environ Microbiol. 2024 Oct 23; 90(10):e0117124.
Score: 0.815
-
The rise, fall, and resurgence of phage therapy for urinary tract infection. EcoSal Plus. 2024 Dec 12; 12(1):eesp00292023.
Score: 0.777
-
A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes. Clin Infect Dis. 2023 10 13; 77(8):1079-1091.
Score: 0.763
-
Class-Driven Synergy and Antagonism between a Pseudomonas Phage and Antibiotics. Infect Immun. 2023 08 16; 91(8):e0006523.
Score: 0.749
-
Antiviral Resistance and Phage Counter Adaptation to Antibiotic-Resistant Extraintestinal Pathogenic Escherichia coli. mBio. 2021 04 27; 12(2).
Score: 0.644
-
Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract. mBio. 2021 02 09; 12(1).
Score: 0.634
-
Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry. mBio. 2020 08 04; 11(4).
Score: 0.612
-
Bacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of Bacteremia. Sci Rep. 2017 04 12; 7:46151.
Score: 0.486
-
Gene discovery from microbial gene libraries I: protection against reactive oxygen species-driven DNA damage. Microbiol Spectr. 2024 Nov 05; 12(11):e0036524.
Score: 0.204
-
Appelmans protocol - A directed in vitro evolution enables induction and recombination of prophages with expanded host range. Virus Res. 2024 01 02; 339:199272.
Score: 0.193
-
Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment. mSphere. 2022 08 31; 7(4):e0034522.
Score: 0.176
-
Considerations for the Use of Phage Therapy in Clinical Practice. Antimicrob Agents Chemother. 2022 03 15; 66(3):e0207121.
Score: 0.169
-
Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection. Viruses. 2021 10 12; 13(10).
Score: 0.166
-
Present and future of microbiome-targeting therapeutics. J Clin Invest. 2025 Jun 02; 135(11).
Score: 0.053